CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 33.24
-0.10 (-0.30%)
At close: Jan 19, 2026
CF PharmTech Market Cap
CF PharmTech has a market cap or net worth of 13.69 billion as of January 20, 2026.
Market Cap
13.69B
Enterprise Value
13.44B
Revenue
647.51M
Ranking
n/a
PE Ratio
460.13
Stock Price
33.24
Market Cap Chart
Since October 8, 2025, CF PharmTech's market cap has decreased from 15.86B to 13.69B, a decrease of -13.68%. That is a compound annual growth rate of -40.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 13.69B | -5.04% |
| Dec 31, 2025 | 14.42B | -9.11% |
| Oct 8, 2025 | 15.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |